Table 4.
No. | Ciprofloxacin MIC (mg/L) | ESBL | qnrB | qnrS | gyrA mutation | parC mutation |
---|---|---|---|---|---|---|
50 | 0.12 | no | no | no | nil | nil |
61 | 0.12 | no | no | no | nil | nil |
125 | 0.12 | no | no | no | nil | nil |
172 | 0.12 | no | no | no | nil | nil |
68 | 0.25 | no | no | no | nil | nil |
93 | 0.25 | no | no | no | nil | nil |
134 | 0.25 | no | no | no | nil | nil |
46 | 0.25 | no | yes | no | nil | nil |
55 | 0.5 | no | no | no | nil | nil |
23 | 0.5 | no | yes | no | nil | nil |
34 | 0.5 | no | no | no | TCC→TAC, Ser83→Tyr | nil |
191 | 1 | no | no | no | nil | nil |
189 | 1 | no | no | yes | nil | nil |
154 | 1 | no | no | no | TCC→TAC, Ser83→Tyr | nil |
208 | 4 | no | yes | no | TCC→TAC, Ser83→Tyr | nil |
103 | 16 | no | no | yes | TCC→TTC, Ser83→Phe | nil |
128 | 16 | no | yes | no | TCC→TTC, Ser83→Phe | nil |
44 | 16 | yes | no | no | TCC→TTC, Ser83→Phe | nil |
35 | 32 | no | no | no | TCC→ATC, Ser83→Phe | AGC→ATC, Ser80→Ile |
9 | 64 | yes | no | yes | TCC→TTC, Ser83→Phe | nil |
45 | 64 | no | yes | no | TCC→ATC, Ser83→Phe | GAA→AAA, Glu84→Lys |
21 | 64 | yes | no | no | TCC→ATC, Ser83→Phe | AGC→ATC, Ser80→Ile |
173 | 64 | no | no | no | TCC→ATC, Ser83→Phe | AGC→ATC, Ser80→Ile |
104 | >128 | yes | yes | no | TCC→ATC, Ser83→Phe | AGC→ATC, Ser80→Ile |